Boehringer Ingelheim Innovation Prize

Established in Boston in 2015 and jointly sponsored by Boehringer Ingelheim and the Boehringer Ingelheim Venture Fund, the prize* facilitates business growth, allowing recipients to focus on developing the next generation of breakthrough medicines. Now also established in San Diego and New York, USA; Tokyo, Japan; Shanghai, China and various innovation ecosystems in Europe; the award provides a platform to show-case ideas and projects from entrepreneurs and start-up organizations.

Shortlisted applicants are invited to present their ideas in a poster session, from which a final short-list is selected to pitch their ideas to a panel of judges. Recent winners have included Valanx Biotech, recognized for its work in creating a site-specific protein conjugation technology platform that can develop cutting-edge treatments in the fields of immuno-oncology and autoimmunity, in our first Innovation Prize in France. And Rubik Therapeutics, a startup focused on next generation programmed cell therapies for solid tumors.

Since its inception in 2015, more than 20 companies have been awarded prizes with a value of more than $1,000,000. 

To find out about future events, please look at our Grass Roots events calendar.
 

*Prizes are adapted according to location and include, for example, free lab space for one year.